Sanghani A - Search Results

1

Novel PEGylated Lipid Nanoparticles Have a High Encapsulation Efficiency and Effectively Deliver MRTF-B siRNA in Conjunctival Fibroblasts.

Sanghani A, Kafetzis KN, Sato Y, Elboraie S, Fajardo-Sanchez J, Harashima H, Tagalakis AD, Yu-Wai-Man C. Sanghani A, et al. Pharmaceutics. 2021 Mar 13;13(3):382. doi: 10.3390/pharmaceutics13030382. Pharmaceutics. 2021. PMID: 33805660 Free PMC article.

2

Advances in exosome therapies in ophthalmology-From bench to clinical trial.

Sanghani A, Andriesei P, Kafetzis KN, Tagalakis AD, Yu-Wai-Man C. Sanghani A, et al. Acta Ophthalmol. 2022 May;100(3):243-252. doi: 10.1111/aos.14932. Epub 2021 Jun 11. Acta Ophthalmol. 2022. PMID: 34114746 Free article. Review.

3

Culturable heterotrophic bacterial diversity study from an Indian lignite mine habitat.

Sanghani AD, Patel RK, Dave SR, Tipre DR. Sanghani AD, et al. Environ Monit Assess. 2023 May 9;195(6):649. doi: 10.1007/s10661-023-11176-y. Environ Monit Assess. 2023. PMID: 37160469

4

Health Care Resource Utilization and Costs of Persistent Severe Acute Kidney Injury (PS-AKI) Among Hospitalized Stage 2/3 AKI Patients.

Koyner JL, Mackey RH, Rosenthal NA, Carabuena LA, Kampf JP, Echeverri J, McPherson P, Blackowicz MJ, Rodriguez T, Sanghani AR, Textoris J. Koyner JL, et al. Among authors: sanghani ar. Kidney360. 2023 Mar 1;4(3):316-325. doi: 10.34067/KID.0005552022. Kidney360. 2023. PMID: 36996299 Free PMC article.

5

Outcomes, Healthcare Resource Utilization, and Costs of Overall, Community-Acquired, and Hospital-Acquired Acute Kidney Injury in COVID-19 Patients.

Koyner JL, Mackey RH, Rosenthal NA, Carabuena LA, Kampf JP, McPherson P, Rodriguez T, Sanghani A, Textoris J. Koyner JL, et al. Among authors: sanghani a. J Health Econ Outcomes Res. 2023 Feb 23;10(1):31-40. doi: 10.36469/001c.57651. eCollection 2023. J Health Econ Outcomes Res. 2023. PMID: 36852155 Free PMC article.

6

Clinical Outcomes of Persistent Severe Acute Kidney Injury among Patients with Kidney Disease Improving Global Outcomes Stage 2 or 3 Acute Kidney Injury.

Koyner JL, Mackey RH, Rosenthal NA, Carabuena LA, Kampf JP, Rodriguez T, Sanghani A, Echeverri J, McPherson P, Blackowicz MJ, Textoris J. Koyner JL, et al. Among authors: sanghani a. Am J Nephrol. 2022;53(11-12):816-825. doi: 10.1159/000528158. Epub 2022 Nov 30. Am J Nephrol. 2022. PMID: 36450235

7

CXCR4 Has the Potential to Enhance Bone Formation in Osteopenic Rats.

Sanghani A, Osagie-Clouard L, Samizadeh S, Coathup MJ, Kalia P, Di Silvio L, Blunn G. Sanghani A, et al. Tissue Eng Part A. 2018 Dec;24(23-24):1775-1783. doi: 10.1089/ten.TEA.2018.0121. Epub 2018 Sep 19. Tissue Eng Part A. 2018. PMID: 29882473

8

Parathyroid hormone 1-34 and skeletal anabolic action: The use of parathyroid hormone in bone formation.

Osagie-Clouard L, Sanghani A, Coathup M, Briggs T, Bostrom M, Blunn G. Osagie-Clouard L, et al. Among authors: sanghani a. Bone Joint Res. 2017 Jan;6(1):14-21. doi: 10.1302/2046-3758.61.BJR-2016-0085.R1. Bone Joint Res. 2017. PMID: 28062525 Free PMC article.

9

Mesenchymal stem cells with increased stromal cell-derived factor 1 expression enhanced fracture healing.

Ho CY, Sanghani A, Hua J, Coathup M, Kalia P, Blunn G. Ho CY, et al. Among authors: sanghani a. Tissue Eng Part A. 2015 Feb;21(3-4):594-602. doi: 10.1089/ten.TEA.2013.0762. Epub 2014 Nov 13. Tissue Eng Part A. 2015. PMID: 25251779 Free PMC article.

10

The potential of stem cell therapy for osteoarthritis and rheumatoid arthritis.

Keerthi N, Chimutengwende-Gordon M, Sanghani A, Khan W. Keerthi N, et al. Among authors: sanghani a. Curr Stem Cell Res Ther. 2013 Nov;8(6):444-50. doi: 10.2174/1574888x1130800062. Curr Stem Cell Res Ther. 2013. PMID: 24016323 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page